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Inﬂ  ammation plays a key role in osteoarthritis (OA). Th  e 
overexpression of cyclooxygenase-2 and proinﬂ  ammatory 
cytokines has been reported to contribute to the develop-
ment of OA. Since chronic inﬂ  ammation is the leading 
cause of connective tissue remodeling and destruction in 
OA, an approach that decreases inﬂ  am  mation  may 
facilitate the development of an eﬀ  ective strategy for its 
treatment and/or prevention. Th   e use of some drugs has 
demonstrated potential in treatment of OA but long-
term safety, resistance and toxicity concerns have 
hindered their long-term acceptance as viable clinical 
chemopreventive agents. Th   e exploration of new agents, 
particularly dietary, with low toxicity that can target 
inﬂ   ammatory responses should form the basis for 
chemopreventive strategies that will reduce the destruc-
tion of cartilage matrix.
Green tea polyphenols (GTPs) – a mixture of major 
polyphenolic constituents found in green tea, including 
(–)-epicatechin, (–)-epigallocatechin, (–)-epicatechin 
gallate and (–)-epigallocatechin-3 gallate (EGCG) – oﬀ  er 
promising new options for the development of more 
eﬀ  ective strategies for the prevention of inﬂ  ammation-
associated diseases, including OA. Th  e recent study by 
Akhtar and Haqqi in Arthritis Research and Th  erapy
indicates that EGCG, the major and most active compo-
nent of GTPs, protects human chondrocytes from IL-1β-
induced inﬂ  ammatory responses, and suggests the poten-
tial of EGCG in OA treatment/prevention [1].
Multiple studies were conducted in the research 
laboratory of Dr Haqqi on the eﬀ  ect of GTPs in arthritis 
using  in vitro and in vivo animal models [2-4]. Th  ese 
studies suggest that GTPs given in drinking water of mice 
prevented collagen-induced arthritis in the mice, and 
that this eﬀ  ect of GTPs was associated with the marked 
reduction of collagen-induced inﬂ  ammatory  mediators 
such as cyclooxygenase-2 and TNFα in arthritic joints of 
GTP-fed mice [2]. In vitro studies showed that treatment 
of human chondrocytes derived from OA cartilage with 
EGCG inhibits IL-1β-induced activity and expression of 
cyclo  oxygenase-2 and inducible nitric oxide synthase, 
and inhibits the production of nitric oxide and prosta-
glandin E2 in chondrocytes. Th  e inhibition of IL-1β-
induced proinﬂ  ammatory mediators by EGCG in human 
chondrocytes was associated with its inhibitory eﬀ  ects 
on the activation and nuclear translocation of NF-κB. 
Th   ese data thus provide a mechanistic link in prevention 
of arthritis responses as well as potential therapeutic 
value for EGCG/GTPs inhibiting cartilage resorption in 
arthritic joints [2-4].
Th  e IL-1 family consists of 11 members including 
IL-1β, and the IL-1 receptor family consists of nine 
separate genes [5]. IL-1β, TNFα and IL-6 are among the 
key cytokines involved in the pathophysiology of OA. A 
recent meta-analysis study showed a small but signiﬁ  cant 
association between carriers of the C-T-A haplotype of 
the Ilirn gene (IL-1 receptor antagonist) and decreased 
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IL-1β is a major cytokine driving the infl  ammatory 
processes leading to the pathophysiology of 
osteoarthritis and other infl  ammatory diseases. 
Blockade of IL-1β activity using substances such as 
the naturally occurring IL-1 receptor antagonist or 
anti-IL-1β monoclonal antibody are currently being 
used or tested as therapy. However, such treatments 
are ineff  ective in osteoarthritis. In a recent study, 
epigallocatechin-3-gallate, a green tea polyphenol, 
was found to be eff  ective in reducing IL-1β-induced 
infl  ammatory cytokines, TNFα, IL-6, granulocyte–
macrophage colony-stimulating factor and several 
chemokines from human chondrocytes. The use 
of green tea polyphenols may be benefi  cial as a 
therapeutic addition to biologics that control IL-1β 
activity by increasing eff  ectiveness and/or reducing 
dosage.
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© 2011 BioMed Central Ltdseverity of OA [6]. IL-1 receptor agonist exerts anti-IL-1β 
inﬂ  ammatory activity by binding to the IL-1 receptor, the 
receptor for both IL-1α and IL-1β [5]. Th   erapeutic use of 
an IL-1 receptor agonist, anakinra, to antagonize IL-1 
(IL-1α and IL-1β) activity is a US Food and Drug 
Administration approved therapy for the treatment of 
rheumatoid arthritis but not for OA due to its limited 
and short-term eﬀ  ectiveness. Maintaining a balance in 
levels of IL-1β might be important as a treatment 
approach for OA, and agents such as GTPs could ﬁ  ll the 
gap. In fact, complete deletion of the Il1b gene leads to 
disease exacerbation in a mouse model of OA, suggesting 
both a catabolic and an anabolic role for IL-1β [7].
Akhtar and Haqqi also showed that GTPs reduce IL-1β-
induced granulocyte–macrophage colony-stimulating 
factor production by chondrocytes [1]. Th   is might be of 
signiﬁ  cance in light of the recent exciting ﬁ  nding that 
IL-1-induced granulocyte–macrophage colony-stimulat-
ing factor is important for the patho  genicity of Th  17, a 
major eﬀ   ector cell driving inﬂ   amma  tion and auto-
immunity [8]. In the photocarcino  genesis model, UV 
radiation-induced inﬂ  ammation has been implicated in 
nonmelanoma and melanoma skin cancers. Topical 
treatment of the mouse skin with EGCG or oral 
administration of GTPs in drinking water of mice 
signiﬁ  cantly inhibited UVB radiation-induced inﬂ  amma-
tory responses, and this eﬀ  ect of GTPs led to prevention 
of UV radiation-induced inﬂ  ammation-associated  skin 
diseases including skin cancers [9,10].
Th   e physician and the patients want to understand the 
real targets and mechanism of action of GTPs that lead to 
the prevention of arthritis/OA. More in vivo studies are 
deﬁ  nitely required to understand the targets of GTPs in 
general, and of EGCG in particular, in arthritic/OA 
animal models. Th  e use of GTPs may be better than 
EGCG as GTPs may have synergistic eﬀ  ects, are more 
stable and are easily aﬀ  ordable. It may also be useful to 
test the eﬀ  ect of EGCG or GTPs in combination with 
other phytochemicals that have anti-inﬂ  ammatory activi-
ties. Additionally, GTPs should be examined in combi  na-
tion with already known drugs for rheumatoid arthritis/
OA. Th   is combination may enhance the chemoprotective 
eﬀ   ect of these drugs, lowering the dose of already 
available drugs that would reduce the toxicity of these 
drugs if used for treatment long term. Th  e road to that 
point will be long but the study by Akhtar and Haqqi is a 
promising start in the right direction.
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